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Introduction
Cognitive theories of depression propose that biases in cognitive 
processes play a key role in the pathogenesis of the depression 
(Gotlib and Joormann, 2010). Depressed patients pay more atten-
tion to negative events and have difficulties in recognizing subtle 
positive emotions and inhibiting negative information (Gotlib 
and Joormann, 2010). Increased negative thoughts about self are 
also characteristic of depression (Northoff, 2007). Depression is 
associated with an increased level of self-focus, rather than pay-
ing attention to the external environment (Northoff, 2007), and 
this is related to an increased experience of negative affect (Mor 
and Winquist, 2002). Self-blame and feelings of worthlessness 
are well-known symptoms of depression, and the self-blame fac-
tor is associated with a higher number of suicide attempts 
(Grunebaum et al., 2005). Ruminative response style is closely 
related to increased self-focus, as it is defined as an individual’s 
focus of attention to his or her negative emotional state (Nolen-
Hoeksema, 1991). Rumination has been found to predict higher 
levels of depression symptoms and longer episodes of depressed 
mood in depressed patients (Nolen-Hoeksema, 1991).
Neuroimaging research has consistently shown that self- 
referential processing is associated with activity of the cortical 
midline structures (CMS), particularly the medial prefrontal cortex 
(MPFC), but also the anterior and posterior cingulate cortex 
(ACC and PCC), the precuneus and the inferior parietal cortex 
(IPC) (Northoff et al., 2006; Van Buuren et al., 2010). Recent 
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research has emphasized the role of these regions in the patho-
genesis of depression. Increased resting state metabolism and 
connectivity of the CMS, particularly the MPFC and ACC, have 
been repeatedly observed in depressed patients (Kaiser et al., 
2015; Northoff, 2007), although decreased connectivity has also 
been reported (Anand et al., 2005; Phillips et al., 2015). Increased 
activity of the CMS, particularly the MPFC, during self-referen-
tial processing, as well as a diminished ability to deactivate these 
regions during emotional tasks, have also been found in depressed 
patients (Lemogne et al., 2012; Sheline et al., 2009). Further, 
some studies have shown that the alterations in the CMS activity 
are associated with increased self-focus and rumination as well as 
with higher levels of depression symptoms (Hamilton et al., 
2011; Lemogne et al., 2012). An inability of the CMS to regulate 
self-referential activity could be essential in the pathogenesis of 
depression (Sheline et al., 2009).
Recently, there has been increasing interest in how antide-
pressants affect the processing of emotional information in the 
brain. Studying the effects of antidepressants in healthy subjects 
facilitates examining the direct actions of antidepressants without 
the confounding effects of depressed mood and mood improve-
ment. Serotonergic and noradrenergic antidepressants have been 
shown to influence emotional processing by, for example, 
increasing recognition of happy facial expressions in healthy vol-
unteers (Harmer et al., 2003a, b, 2008; Murphy et al., 2009), 
though not all the studies have been able to replicate this finding 
(Browning et al., 2007; Harmer et al., 2004). This effect is rapid, 
within hours or days from administration, despite the well-known 
delay in the clinical effect of antidepressants (Harmer and 
Cowen, 2013). In healthy volunteers, amygdala responses to 
negative visual stimuli seem to decrease as fast as a few hours or 
days after administration of several different antidepressants 
(Anderson et al., 2007; Del-Ben et al., 2005; Murphy et al., 2009; 
Norbury et al., 2007; Takahashi et al., 2005), even though 
increased amygdala responses (Bigos et al., 2008) or no effect at 
all (Norbury et al., 2007) have been reported in some studies. 
Recent meta-analysis also found both decreased and increased 
amygdala responses to negative stimuli after a single dose of 
antidepressant (Ma, 2014). These rapid changes in emotional 
processing are mostly opposite to the negative bias in informa-
tion processing of depressed patients, and thus, antidepressants 
may be able to rapidly reverse this negative bias, which may be 
central to their antidepressant effect. However, although self-
referential processing is a core issue in pathogenesis of depres-
sion, the effects of antidepressants on self-referential processing 
remain elusive. A one-week administration of reboxetine was 
found to increase activity of fronto-parietal regions during cate-
gorization of positive self-referential words, and to decrease their 
activity during subsequent recognition of positive self-referential 
words (Norbury et al., 2008). The authors suggested this may 
indicate enhanced salience to positive cues and, consequently, 
reduced retrieval efforts for these words. A single dose of rebox-
etine, on the other hand, had no effect on neural responses to 
categorization of self-referential words. (Miskowiak et al., 2007). 
A three-week administration of escitalopram in healthy volun-
teers decreased responses of the PCC to self-referential words 
(Matthews et al., 2010).
Mirtazapine is a commonly-used antidepressant that has com-
plex effects on serotonergic and noradrenergic transmission. It 
increases serotonin and norepinephrine release by blocking 
presynaptic alpha 2 receptors, and has additional antagonist 
action on 5HT2A, 5HT2C and 5HT3 receptors (Fawcett and Barkin, 
1998). It is also a high-affinity antagonist at the histamine H1 
receptor (Fawcett and Barkin, 1998). The clinical profile of mir-
tazapine is different from that of SSRIs, as mirtazapine has an 
early anxiolytic effect (Fawcett and Barkin, 1998), possibly due 
to 5HT2A and 5HT2C antagonism (Quesseveur et al., 2012), as 
well as 5HT3 (Olivier et al., 2000) and H1 blockage (Lader and 
Scotto, 1998). By contrast, SSRIs may increase anxiety and agi-
tation in some patients at treatment initiation, and a similar early 
anxiogenic effect has been described in animal studies also 
(Handley, 1995). This may explain why a single dose of SSRI 
citalopram increases recognition of fearful facial expressions, 
and repeated administration decreases it (Browning et al., 2007; 
Harmer et al., 2004), whereas mirtazapine decreases threat pro-
cessing immediately after a single dose (Arnone et al., 2009). 
This makes the early effects of mirtazapine easier to interpret, 
thus rendering mirtazapine an appealing agent for evaluating the 
effects of antidepressants on emotional processing. Rawlings 
et al. (2010) found decreased right amygdala–hippocampal and 
fronto-striatal activation compared with placebo after a single 15 
mg dose of mirtazapine in response to fearful versus happy facial 
expressions. Another study noted increased activation after 30 
mg of mirtazapine relative to placebo in the IPC in response to a 
reward task of financial gain (Vollm et al., 2006). Thus, mirtazap-
ine may rapidly decrease neural responses to threatening stimuli 
and increase responses to positive or rewarding stimuli. However, 
it remains unknown whether/how mirtazapine influences self-
referential processing. Considering the importance of self-refer-
ential processing and the underlying brain network in depression, 
this could significantly help to elucidate the systems-level mech-
anisms of action of mirtazapine.
Here we investigated the effects of a single dose of mirtazap-
ine on self-referential processing in healthy volunteers. We quan-
tified the effect on positive and negative self-referential 
processing separately, as mirtazapine is known to have the above-
mentioned valence-specific effects on emotional processing. 
Based on previous evidence of the effect of mirtazapine on pro-
cessing of emotional information (Arnone et al., 2009; Rawlings 
et al., 2010) and the effect of two other monoaminergic antide-
pressants, reboxetine (Miskowiak et al., 2007; Norbury et al., 
2008) and escitalopram (Matthews et al., 2010), on self-referen-
tial processing, we hypothesized that mirtazapine would decrease 
responses of the CMS to negative self-referential processing and 
increase responses to positive self-referential processing.
Methods and materials
Subjects
The participants were 30 healthy, native Finnish-speaking, right-
handed volunteers aged 18–35 years. They were recruited via 
advertisement for university students and word of mouth. The 
participants were screened with the Structured Clinical Interview 
for DSM-IV Axis I Disorders (First et al., 2002). Exclusion crite-
ria included any current or life-time psychiatric disorder, current 
use of illicit drugs or excessive consumption of alcohol (>24 
units/week for men and >16 units/week for women) and use of 
antidepressants, antipsychotic agents, mood stabilizers, systemic 
corticosteroids, beta blockers or benzodiazepines. The study was 
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approved by the Ethics Committee of Helsinki and Uusimaa 
Hospital District and conducted in accordance with the ethical 
standards of this committee. Written informed consent was 
obtained from each participant.
The participants were allocated into two groups to either 
receive a single dose of mirtazapine 15 mg two hours prior to the 
fMRI, or to be scanned without mirtazapine as a control group in 
an open-label design. The study was originally designed as a ran-
domized, placebo-controlled, double-blind, parallel-group design 
with a 30 mg dose of mirtazapine, but after scanning ten partici-
pants the double-blinding was deemed impossible due the seda-
tive effect of mirtazapine. Consequently the blinding was in 
effect broken for both researcher and subject, and the study was 
re-designed as an open-label protocol with a smaller mirtazapine 
dose of 15 mg. During the open-label phase we had to exclude six 
participants from the mirtazapine group due to excessive seda-
tion or sleeping during the fMRI (participant told that she/he had 
fallen asleep during the task, or was asleep after the task, or if 
there were more than 10% of un-responded items in the task). 
Data collection was continued until there were 15 subjects with-
out excessive sedation in both groups (six male, 24 female, mean 
age 24 years, SD 3.72). Thus the final sample size for the fMRI 
analysis was 30 participants. However, in the behavioural tasks 
one subject from the drug group was excluded from the analysis 
of categorization accuracy and reaction times because of missing 
data due to a technical problem. One subject from the control 
group was excluded as an outlier due to extremely long reaction 
times (>3SD from the group mean), resulting in a final sample of 
28 participants in these analyses. One subject from the mirtazap-
ine group had to be excluded from the recall memory test due to 
missing data resulting in a final sample of 29 participants.
Questionnaires
Two hours before the fMRI, the participants completed question-
naires including the Beck Depression Inventory (BDI-II (Beck 
et al., 1961)), the Beck Anxiety Inventory (BAI (Beck et al., 
1988)) and a questionnaire about current affective states using 
words adapted from Russell’s circumplex model of affect 
(Russell, 1980) on a five-point Likert scale. The words formed a 
circumplex with two dimensions, valence and arousal: tired 
(väsynyt) and bored (pitkästynyt) (negative valence, low arousal), 
sad (surullinen) and miserable (onneton) (negative valence, neu-
tral arousal), nervous (hermostunut) and anxious (ahdistunut) 
(negative valence, high arousal), active (aktiivinen) and aroused 
(vireä) (high arousal, neutral valence), excited (innostunut) and 
peppy
(pirteä) (positive valence, high arousal), cheerful (iloinen) 
and happy (onnellinen) (positive valence, neutral arousal), con-
tent (tyytyväinen) and calm (tyyni) (positive valence, low 
arousal) and tranquil (rauhallinen) and passive (passiivinen) (low 
arousal, neutral valence). The assessment of affective states was 
repeated right before the fMRI, two hours after the first 
assessment.
Task and stimuli for fMRI
During fMRI the participants completed an emotional categori-
zation task (Miskowiak et al., 2007). The stimuli consisted of 60 
adjectives describing 30 unequivocally positive (e.g. honest, reli-
able, sympathetic) and 30 unequivocally negative (e.g. irrespon-
sible, selfish, lazy) personality features in Finnish and 20 neutral 
words, namely ten times ‘left’ (vasen) and ten times ‘right’ 
(oikea). The words were presented in an event-related design for 
one second in random order, with an inter-stimulus interval ran-
domly varying between 5000 ms and 9500 ms. The Presentation 
software (Neurobehavioral Systems Inc., Albany, USA) con-
trolled the stimulus delivery. Total duration of the task was 11 
minutes. The participants were asked to imagine overhearing two 
people talking about him or her using the word presented on the 
screen. They were asked to imagine how they would feel and 
accordingly categorize the words as either positive or negative as 
quickly and accurately as possible. The categorizing was done 
with a response key box with two keys on their right hand. They 
were asked to press the left button (index finger) if the word was 
positive (i.e. they would feel pleasant when being described with 
the word) and right button (middle finger) if the word was nega-
tive (i.e. they would feel unpleasant). When the word ‘left’ was 
presented, they were asked to press the left button and when the 
word ‘right’ was presented the right button.
After fMRI the participants completed a surprise memory test 
of the adjectives in the fMRI task. This took place approximately 
1.5 hours after the categorization test because of other assess-
ments unrelated to the present protocol. In the free recall task, the 
participants were asked to write down as many words as they 
could remember from the categorization task. After this, they 
completed a recognition memory task. Sixty adjectives from the 
categorization task (targets) and 60 new adjectives (distracters) 
were shown on a computer screen for one second in a random 
order. The participants were asked to respond with key presses as 
quickly and accurately as possible, indicating whether or not 
each word was presented in the categorization task. The next 
word appeared on the screen only after participants responded. 
The distracters were matched with the target words by length 
(mean of targets 9.1 characters, mean of distracters 9.0 charac-
ters, t=0.36, p=0.719), frequency (database of word frequencies 
in Finnish through WWW-Lemmie 2.0, which is a web-based 
tool for dynamic corpus work in the Language Bank of Finland, 
administered by CSC – IT Centre for Science Ltd in Espoo, 
Finland; mean of targets 53.6, mean of distracters 53.6, t=–0.002, 
p=0.998) and imageability (rated by the research group similarly 
as in (Cortese and Fugett, 2004); mean of targets 2.3, mean of 
distracters 2.3, t=0.08, p=0.937).
Statistical analysis of baseline 
characteristics, questionnaires and 
behavioural data
Statistical analyses of baseline characteristics, questionnaires and 
behavioural data were performed with SPSS Statistics software, 
version 21 (IBM Corporation, Armonk, USA). We analysed the 
baseline characteristics (age and comprehensive school grade 
point average) using independent samples t-test. A non-paramet-
ric Mann–Whitney U-test was used for baseline questionnaires 
BDI and BAI because of their skewed distributions in the study 
sample. For the affective state questionnaire, we analysed each 
sector of the circumplex separately (negative affect (NA), posi-
tive affect (PA), negative affect with high arousal (NA-HA), 
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positive affect with high arousal (PA-HA), negative affect with 
low arousal (NA-LA), positive affect with low arousal (PA-LA), 
high arousal (HA) and low arousal (LA)). Change in each sector 
was calculated separately for each subject by subtracting assess-
ment at time 1 from assessment at time 2, and these differences 
were then compared between the two groups using an independ-
ent samples t-test. We additionally compared the single item of 
‘tiredness’ assessed right before fMRI (i.e. assessment at time 2) 
between the groups to assess sedation. A Mann–Whitney U-test 
was used to analyse accuracy of categorizing positive and nega-
tive words and to compare the number of intrusions (incorrect 
answers) between the groups in the free recall test (because 
of the skewed distributions). A repeated measures ANOVA 
(group×valence) was used to compare the reaction times between 
the groups in the emotional categorization task and to compare 
the number of correct words in the free recall test. For the word 
recognition task, we first calculated the non-parametric discrimi-
nation index A´ (Grier, 1971) to eliminate the effect of possible 
response biases. The discrimination index A´ varies typically 
between 0.5 (chance level, hits=false alarms) and 1 (perfect rec-
ognition, hits=100%, false alarms=0%). It was calculated using a 
formula: A’=0.5+[(H-FA)(1+H-FA)]/[(4H(1-FA)], where H=hits/
targets and FA=false alarms/distractors. A repeated measures 
ANOVA (group×valence) was conducted to compare the perfor-
mance of the two groups.
fMRI acquisition and analysis
The MRI was performed on a 3 T MAGNETOM Skyra whole-
body scanner (Siemens Healthcare, Erlangen, Germany) at the 
Advanced Magnetic Imaging Centre, Aalto NeuroImaging, Aalto 
University School of Science, Espoo, Finland. The images were 
acquired with a T2*-weighted echo-planar imaging (EPI) 
sequence consisting of 33 slices (TR 1700 ms, TE 24 ms, FOV 
202 mm, flip angle 70°, voxel size 3×3×4 mm, ascending inter-
leaved acquisition with no gaps between slices). A total of 385 
volumes were acquired, preceded by three dummy scans to avoid 
equilibration effects. T1-weighted structural images were acquired 
at a resolution of 1×1×1 mm (TR 2530 mm, TE 3.3 mm).
Functional MRI data were preprocessed and analysed with 
SPM8 software (http://www.fil.ion.ucl.ac.uk/spm/). EPI images 
were corrected for slice acquisition time, realigned to the first 
scan by rigid-body transformation to correct head movements, 
and co-registered to the individual’s structural MRI. The anatom-
ical image was then normalized to standard template (Montreal 
Neuroimaging Institute template) using SPM’s unified segmenta-
tion/normalization algorithm (New Segment tool) (Ashburner 
and Friston, 2005), and the resulting deformation field was 
applied to the EPI images. Finally, EPI images were smoothed 
with Gaussian kernel of FWHM 8 mm.
A random-effects model was implemented using a two-stage 
process. The first-level (within-subject) general linear model 
(GLM) included three explanatory variables – negative adjectives, 
positive adjectives and neutral words – and realignment parame-
ters as effects of no interest to account for motion-related variance. 
A high-pass filter of 60 s and AR(1) modelling of temporal auto-
correlation were applied. Individual contrast images were com-
puted for the following contrasts: all adjectives>neutral words, 
positive adjectives>neutral words, negative adjectives>neutral 
words, positive adjectives>negative adjectives and negative 
adjectives>positive adjectives. The second-level analysis used 
these images in a new GLM, which generated statistical images, 
that is, SPM t-maps. The statistical threshold was set at p<0.05, 
FDR corrected at cluster level (primary voxel-wise threshold at 
p<0.05). Cluster-extent based thresholding increases sensitivity 
and takes into account the spatial relationship of the activation foci 
with each other (Friston et al., 1994). However, it does not deter-
mine the statistical significance of an activation at a specific loca-
tion in the cluster, and thus has low spatial specificity when the 
clusters are large (Woo et al., 2014).
To reveal the brain regions involved in self-referential pro-
cessing, we first tested the aforementioned contrasts in the 
unmedicated control group only using one-sample t-test. In this 
analysis, the primary voxel-wise threshold was set at p<0.01, the 
FDR-corrected cluster-level threshold being the same p<0.05 as 
in all analyses. Next, the effect of mirtazapine was assessed by 
comparing responses in the drug group and the control group 
with independent samples t-test. We performed one further 
exploratory analysis for the regions with significant group differ-
ences in self-referential processing (all adjectives>neutral words) 
by extracting signal change (parameter estimates) for all stimulus 
types relative to baseline fixation (positive adjectives>baseline, 
negative adjectives>baseline, neutral words>baseline) from this 
cluster and comparing the groups using independent samples 
t-test.
Finally, we determined whether the sedative effect of mir-
tazapine could confound the between-group comparisons. We 
added the participants’ self-assessment of tiredness (right before 
fMRI, i.e. assessment 2) as a covariate in the second level model 
(one-sample t-test) of the drug group separately. If there is any 
strong correlation between sedation level and fMRI-responses, 
adding the covariate to the one-sample t-test in the medication 
group should diminish the responses markedly. We also per-
formed additional analyses of group differences, including tired-
ness assessment as a general covariate.
Results
Baseline characteristics and questionnaires
No significant differences emerged between the groups in age, 
comprehensive school grade point average, BDI, BAI (p>0.05 in 
all, see Table 1) or gender (3/15 male in both groups). In the affec-
tive state questionnaire (Table 2), there was a significant differ-
ence between the groups in change (difference between assessment 
1 and assessment 2) in NA-LA (mean 2.00/0.43, mirtazapine/con-
trol, t=4.09, p=0.001), PA-HA (mean –1.20/0, mirtazapine/con-
trol, t= –2.23, p=0.034), HA (mean –1.67/–029, mirtazapine/
control, t= –2.10, p=0.045) and LA (mean 0.93/–0.07, mirtazap-
ine/control, t=2.08, p=0.048). There was a significant difference 
between the groups in subjective tiredness assessed right before 
fMRI (i.e. assessment at time 2, mean 3.20/1.93 mirtazapine/con-
trol, t=3.40, p=0.002).
Behavioural tasks
No significant differences were present between the groups in 
accuracy of categorizing positive or negative personality trait 
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words (Table 3). In repeated measures ANOVA (group×valence), 
both groups had significantly faster reaction times for positive 
than negative words (effect of valence F(1, 26)=7.26, p=0.012), 
but no main effect of group or valence×group interaction was 
found (Table 4). In the free recall task, the control group recalled 
more positive and negative words than the mirtazapine group 
(main effect of group F(1, 27)=5.52, p=0.026, see Table 4). 
There was no significant difference in the number of incorrect 
answers between the groups. In the recognition memory task, 
the mirtazapine group performed worse than the control group, 
and the difference was significant in ANOVA (main effect of 
group F(1, 28)=9.67, p=0.004). No difference was found in per-
formance between positive and negative words either within or 
between groups.
fMRI results
Self-referential processing in the control group. Self-referen-
tial processing (all adjectives>neutral words) was associated with 
stronger activation of bilateral DMPFC and VMPFC extending to 
the ventral ACC, left PCC, left ventrolateral prefrontal cortex and 
orbitofrontal cortex (left orbitofrontal gyrus and inferior frontal 
gyrus), left hippocampus, left temporal cortex (left temporal pole, 
also a more posterior part of middle and inferior temporal gyri), 
left IPC (angular gyrus), bilateral occipital cortex (cuneus, lingual 
gyrus, fusiform gyrus) and cerebellum (Figure 1).
Negative self-referential processing (negative adjectives> 
neutral words) increased activation of the same regions. 
However, the IPC was not activated in this contrast. Positive 
self-referential processing (positive adjectives>neutral words) 
also activated similar regions and, additionally, the right amyg-
dala. The contrast ‘negative>positive adjectives’ activated the 
left anterior insula and striatum (putamen and pallidum). No sig-
nificant activation was found in the contrast ‘positive>negative 
adjectives’. However, with a more lenient primary voxel-wise 
threshold of p<0.05 (cluster-level FDR-corrected threshold 
Table 1. Demographic characteristics and baseline ratings of mood and 
anxiety.
Mean 
mirtazapine
Mean 
control
t value (p)
Age 23.5 23.8 –0.22 (0.825)
Grade point 
average
9.0 9.2 –1.52 (0.140)
 Median 
mirtazapine
Median 
control
p (Mann–Whitney 
U-test)
BDI 0.0 1.0 0.132
BAI 2.0 3.0 0.239
BDI: Beck Depression Inventory; BAI: Beck Anxiety Inventory.
Table 2. Differences between assessment 2 and assessment 1 in each 
dimension of circumplex of the affective state questionnaire.
Mean 
mirtazapine 
(SD)
Mean control 
(SD)
t value (p)
PA change –0.40 (0.51) –0.64 (1.08) 0.76 (0.454)
NA change 0 (0.38) –0.07 (0.83) 0.30 (0.765)
PA-HA change –1.20 (1.42) 0 (1.47) –2.23 (0.034)
PA-LA change –0.27 (0.88) –0.14 (0.77) –0.40 (0.692)
NA-LA change 2.00 (1.96) –0.43 (1.16) 4.09 (0.001)
NA-HA change –0.20 (0.68) 0.36 (0.84) –1.97 (0.059)
LA change 0.93 (1.28) –0.07 (1.33) 2.08 (0.048)
HA change –1.67 (1.84) –0.29 (1.64) –2.10 (0.045)
PA: positive affect; NA: negative affect; LA: low arousal; HA: high arousal.
Table 3. Categorization accuracy (proportion of correct responses) for 
the mirtazapine and control groups in the emotional categorization 
task.
Median 
mirtazapine
Median 
control
p (Mann–Whitney 
U-test)
Categorization 
accuracy %
Positive
Negative
97
100
100
100
0.178
0.356
Table 4. Performance in the emotional categorization and memory tasks for the mirtazapine and control groups.
Mirtazapine Control Main effect of valence Main effect of group Interaction
 Mean SD Mean SD F p F p F p
Categorization 
response times, 
ms
Positive
Negative
963.9
1054.0
264.29
362.68
969.6
1019.8
256.32
259.76
F(1, 26)=7.256 0.012 F(1, 26)=0.018 0.894 F(1, 26)=0.588 0.450
 
Free recall 
correct responses
Positive
Negative
3.36
3.14
2.34
2.03
5.33
4.80
2.64
2.08
F(1, 27)=1.114 0.301 F(1, 27)=5.524 0.026 F(1, 27)=0.203 0.656
 
Recognition 
accuracy
 
hits/targets % Positive 60.00 19.19 67.56 14.06  
 Negative 52.67 17.82 60.67 20.05  
false alarms/
distractors %
Positive
Negative
35.40
22.89
15.38 21.38 12.92  
13.62 17.78 10.74  
A’ Positive 0.68 0.13 0.82 0.07 F(1, 28)=1.091 0.305 F(1, 28)=9.669 0.004 F(1, 28)=2.926 0.098
 Negative 0.73 0.12 0.81 0.09  
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p<0.05), we observed increased responses of the MPFC, ACC, 
MCC and PCC, as well as the bilateral amygdala–hippocampal 
complex and thalamus to positive as compared to negative self-
referential words.
Effects of mirtazapine. Mirtazapine decreased responses 
of the bilateral DMPFC, right VMPFC and right ventral 
ACC (Figure 2, Table 5) to self-referential processing (all 
adjectives>neutral words). No significant differences were 
found between the mirtazapine and control groups in nega-
tive self-referential processing (negative adjectives>neutral 
words). However, we observed a trend towards decreased 
responses of the DMPFC in the mirtazapine group (uncorrected 
cluster-level p=0.008). Mirtazapine decreased responses to 
positive self-referential processing (positive adjectives>neutral 
words) in the bilateral anterior CMS including the DMPFC, 
VMPFC and ventral ACC, the parietal cortex including left 
IPC (angular gyrus), the bilateral PCC and precuneus and the 
occipital cortex including the primary (cuneus) and secondary 
(lingual gyrus) visual cortices (Figure 3, Table 5). When com-
paring positive versus negative self-referential processing 
(positive adjectives>negative adjectives), mirtazapine was 
associated with decreased responses of the bilateral PCC and 
precuneus, the bilateral hippocampus, the parahippocampal 
gyrus and amygdala, the left anterior and posterior parts of 
temporal cortex (middle temporal gyrus) and the left fusiform 
gyrus (Table 5). No significantly decreased responses were 
found when comparing negative versus positive self-referen-
tial processing (negative adjectives>positive adjectives). Add-
ing subjective sedation (tiredness) as a covariate in the 
mirtazapine group, one-sample t-test of each contrast did not 
essentially change the results. There was no significant main 
effect of tiredness. Adding tiredness as a covariate in the analy-
sis of group differences did not weaken the results.
In the complementary region-of-interest analysis of 
signal change, we found decreased responses to both positive 
and negative self-referential adjectives in the anterior 
CMS cluster (Figure 2, Table 6) in the mirtazapine group 
relative to the control group. Importantly, no significant 
differences were seen in responses to neutral words between 
the groups.
Figure 1. Brain regions with significantly increased responses to 
self-referential processing (all adjectives>neutral words) in the 
un-medicated control group (p<0.05, FDR corrected at cluster level 
(primary voxel-wise p<0.01)). HPC: hippocampus; MPFC: medial 
prefrontal cortex; MTG: medial temporal gyrus; OFC: orbitofrontal 
cortex; PCC: posterior cingulate cortex; vACC: ventral anterior cingulate 
cortex; V1/V2: primary and secondary visual cortex.
Figure 2. (a) Brain regions with significantly decreased responses to self-referential processing (all adjectives>neutral) in the mirtazapine group 
relative to the control group (p<0.05, FDR corrected at cluster level). (b) Plot of mean signal change (parameter estimates) extracted from the 
significant cluster for all stimulus types relative to baseline fixation. Error bars represent standard error of mean. *p<0.05. DMPFC: dorsomedial 
prefrontal cortex; VMPFC: ventromedial prefrontal cortex; vACC: ventral anterior cingulate cortex.
Table 5. Peak activations of the clusters showing significant activation in the control group compared to mirtazapine group (p<0.05, FDR-corrected 
at cluster level).
Contrast Region p-value z-value Coordinates
Self-referential>neutral MPFC/ACC 0.043 4.20  18, 40, –8
Positive>neutral MPFC/ACC 0.001 4.07  18, 42, –8
Positive>negative occipital/parietal 0.016 3.49  28, –52, 8
temporal/parietal 0.001 3.62 –22, –40, –10
MNI coordinates refer to peak activation within each cluster.
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Discussion
We show for the first time that a single dose of mirtazapine influ-
ences self-referential processing in healthy volunteers. The 
results go significantly beyond the previous findings about the 
early effects of mirtazapine on sensory emotional processing 
(Arnone et al., 2009; Rawlings et al., 2010) and suggest that 
down-regulation of self-referential processing in the CMS may 
be a potential mechanism of action of antidepressants.
Mirtazapine influences self-referential 
processing
We found that self-referential processing of emotional adjectives 
activated the expected cortical midline areas (MPFC and ACC, 
PCC, precuneus) in non-medicated subjects. In line with previ-
ous studies, the activation foci extended to the left lateral pre-
frontal cortex and orbitofrontal cortex, left hippocampus, left 
temporo-parietal cortex, occipital cortex and cerebellum (Di 
Simplicio et al., 2012; Lane et al., 1997; Northoff, 2007; Van 
Buuren et al., 2010).
Our main finding was that mirtazapine decreases responses of 
the CMS to self-referential words at only two hours after a single 
dose. This is in accord with the previously reported early effect of 
two monoaminergic antidepressants, reboxetine and escitalopram, 
on self-referential processing of healthy volunteers (Matthews 
et al., 2010; Norbury et al., 2008). However, opposite to the effect 
of reboxetine reported previously, we found decreased responses, 
particularly to positive self-referential processing, whereas any 
decrease in responses to negative self-referential processing did 
not reach statistical significance. This seems counter-intuitive, 
and contrary to our expectations, as depressed patients are known 
to have a negative bias in information processing, and previous 
reports have shown that mirtazapine, as well as other antidepres-
sants, is able to increase positive bias in healthy volunteers 
(Arnone et al., 2009; Norbury et al., 2008; Rawlings et al., 2010). 
However, our results in the post hoc analysis of signal change in 
the anterior CMS indicate that, in this area, activity was signifi-
cantly decreased in the mirtazapine group relative to the control 
group in response to both positive and negative words. Acute ver-
sus chronic or subchronic administration may also be an impor-
tant issue here; reboxetine was previously found to decrease 
responses to negative self-referential words after repeated admin-
istration, but not after a single dose (Miskowiak et al., 2007; 
Norbury et al., 2008). Interestingly, a recent meta-analysis also 
showed that acute effects of antidepressants on neural responses 
to negative stimuli seem to be both decreasing and increasing, but 
after repeated administration, consistently decreasing (Ma, 2014).
The tendency of healthy individuals to more likely evaluate 
positive information as self-descriptive (Moran et al., 2006), and 
increased responses of the CMS to positive vs negative self-refer-
ential processing found previously (Norbury et al., 2007) and here, 
may also influence our results. Mirtazapine may have a stronger 
attenuating effect on neural responses to positive adjectives 
because they are experienced as more self-related than negative 
adjectives. This remains, however, speculative, since we did not 
ask participants to provide evaluations about the self-relatedness of 
the words. The association of the valence of self-referential mate-
rial with the modulating effect of mirtazapine might be different in 
depressed persons to healthy individuals. The attenuating effect of 
mirtazapine on positive self-referential processing could also 
reflect a general negative effect of serotonergic antidepressants on 
affective experience, which is sometimes reported (Price et al., 
2009). This is supported by the mirtazapine-related decrease in 
positive affect–high arousal affective state and increase in negative 
affect–low arousal affective state observed here. However, this 
should be interpreted with caution, because the sedative effect of 
mirtazapine may alternatively explain the observed group differ-
ences in affective states, as we only found differences in positive 
and negative affect with the arousal dimension (including words 
‘peppy’ and ‘tired’, respectively).
Studies consistently implicate the role of the CMS, especially 
the MPFC and ACC, in the pathogenesis of depression (Drevets 
et al., 2008). Further, a recent meta-analysis suggests that the mid-
line structures such as the ACC, PCC, OFC and MPFC are 
affected by antidepressant treatment in response to emotional 
tasks in depressed patients and healthy subjects (Ma, 2014). 
Furthermore, the ACC appears to be a promising area to predict 
treatment response of depressed patients across different interven-
tions, including antidepressant medication, transcranial magnetic 
stimulation and psychotherapy (Pizzagalli, 2011).The increased 
self-focus in depression is an important target of psychotherapy. 
For example, mindfulness-based cognitive therapy that specifi-
cally aims to increase awareness of and disengagement from neg-
ative self-focused thinking has been shown to prevent relapses of 
recurrent depression (Teasdale et al., 2000). It is possible that a 
down-regulated self-referential processing is essential for thera-
peutic effect across different treatment interventions, including 
antidepressant medication, and, especially, the anterior CMS may 
Figure 3. Brain regions with significantly decreased responses to 
positive self-referential processing (positive adjectives>neutral) in the 
mirtazapine group relative to the control group (p<0.05, FDR corrected 
at cluster level). DMPFC: dorsomedial prefrontal cortex; IPC: inferior 
parietal cortex; PCC: posterior cingulate cortex; VMPFC: ventromedial 
prefrontal cortex; vACC: ventral anterior cingulate cortex; V1/V2: 
primary and secondary visual cortex.
Table 6. Signal change (parameter estimates) extracted from the 
significant cluster in the medial prefrontal cortex and anterior 
cingulate cortex.
Mean 
mirtazapine 
(SD)
Mean 
control 
(SD)
t value (p)
Positive>baseline 0.77 (0.54) 1.42 (0.89) –2.41 (0.023)
Negative>baseline 0.86 (0.55) 1.52 (0.80) –2.61 (0.014)
Neutral>baseline 0.55 (1.30) 0.80 (0.79) –0.64 (0.530)
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be an important neural substrate for this change. Mirtazapine can 
potentially influence the anterior CMS, as it is known to have a 
high binding potential in cortical regions (Smith et al., 2008) and 
the MPFC has a high density of particularly 5HT2a receptors 
(Fisher et al., 2009).
The role of the anterior CMS in the pathogenesis of depres-
sion and the mechanisms of antidepressant treatments may be 
understood via their role in integrating information from the lim-
bic, self-referential (CMS) and cognitive (including dorsolateral 
prefrontal cortex (DLPFC)) networks, all of which have been 
shown to be altered in depression (Kaiser et al., 2015; Lemogne 
et al., 2012). The anterior CMS are thought to act as a hub to link 
sensory, visceral and emotional signals to self-referential pro-
cesses (Northoff, 2007; Northoff et al., 2006). The DLPFC is 
implicated in higher-order processing, which seems to be recip-
rocally linked to self-referential processing (Northoff et al., 
2006). It has been argued that in depression hyperactivity of the 
anterior CMS and lack of inhibition from the DLPFC – that is, 
dominance of the self-referential network over the cognitive net-
work – could lead to increased self-focus and rumination 
(Hamilton et al., 2011; Nejad et al., 2013). Overly-increased self-
focus alongside and integrated with negative bias in information 
processing can form a vicious circle that maintains and reinforces 
depression (Northoff, 2007). Our results show that mirtazapine 
rapidly reduces responses of the CMS to self-referential informa-
tion. This could lead to improved regulation of self-referential 
and emotional processing, which in depressed patients may result 
in decreased self-focus and rumination and improved ability to 
focus on the external world. 
Limitations
We did not include a control condition with adjectives processed 
in a non-self-referential manner. This leaves open the possibility 
that the effect of mirtazapine observed here was due to emo-
tional rather than self-referential content of the words; however, 
given the foci of the observed changes (the CMS rather than the 
limbic circuit), this does not seem likely. Using cluster-extent 
based thresholding hinders the spatial specificity of the results, 
as we found rather large significant clusters. However, even 
though the specific voxel-level location of the drug effect within 
the clusters remains elusive, the significant drug effects fall into 
the expected CMS.
We used an open-label design because the sedative effect of 
mirtazapine makes blinding practically impossible. Thus, the 
sedative effect of mirtazapine also complicates interpretation of 
the results, as it could be argued that the sedative effect is driving 
the differences between the groups in brain activation. This is 
unlikely for a number of reasons. First, adding the subjective 
tiredness as a covariate in the drug group model had essentially 
no influence on the responses of each event type. Furthermore, 
adding tiredness as a covariate in the analysis of group differ-
ences did not weaken the results. However, tiredness is not a 
direct measurement of sedation, and the lack of specific assess-
ment of sedation should also be considered as a limitation of the 
study. Second, we did not find any differences in task reaction 
times between the two groups, indicating that any sedation in the 
drug group did not influence motor behaviour known to be sensi-
tive to sedative effects (Kim et al., 2004). However, performance 
in the memory task was worse in the mirtazapine group. This 
may be related to sedation, but the memory effects of sedative 
drugs have also been argued to be a separate phenomenon from 
the sedation (Veselis et al., 2001; Wezenberg et al., 2007). The 
study sample was rather small and this makes it difficult to judge 
the clinical meaning of this secondary finding of reduced mem-
ory performance in the drug group. Third, we observed no 
between-group differences in neural responses to neutral words 
only. The selective effects of mirtazapine on emotional self-refer-
ential processing thus confirm that sedation does not play a major 
role in the observed findings.
It is also important to bear in mind that we studied acute 
effects of mirtazapine in healthy volunteers, and thus any inter-
pretations about the long-term effects of mirtazapine, particularly 
in clinical populations, are speculative.
Conclusion
Mirtazapine decreases responses of the CMS to emotional self-
referential processing at only two hours after a single dose. These 
regions support self-referential processing and are implicated in 
the pathogenesis of depression. Our results suggest that mirtazap-
ine can rapidly improve the ability of the CMS to down-regulate 
self-referential activity, which may lead to decreased self-focus 
and rumination, contributing to the antidepressant effect of mir-
tazapine. The results highlight the importance of the CMS and 
self-referential processing in the neuronal effects of antidepres-
sants. Understanding these mechanisms can help to develop new 
treatment interventions specifically targeted at these mechanisms, 
and to predict the treatment response to various interventions.
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